OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 5 citing articles:

2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents
Jørn Herrstedt, Luigi Celio, PJ Hesketh, et al.
Supportive Care in Cancer (2023) Vol. 32, Iss. 1
Open Access | Times Cited: 19

Olanzapine for the prevention of postoperative nausea and vomiting after gynecologic laparoscopic surgery: a randomized controlled trial
Nanjin Chen, Shuman Ji, Junfei Liu, et al.
Therapeutic Advances in Drug Safety (2024) Vol. 15
Open Access | Times Cited: 2

Pharmacokinetics, pharmacodynamics, safety, and tolerability of dopamine-receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting
Adile Orhan, Carolyn V. Nguyen, Alexandre Chan, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 6, pp. 473-489
Closed Access | Times Cited: 2

Feasibility of single low-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting: a single-centre case series
Harish Kamaraj, Natarajan Viswanathan, Ardhra Jiju, et al.
Journal of Drug Delivery and Therapeutics (2024) Vol. 14, Iss. 12, pp. 15-19
Open Access

Acute Metabolic Shifts: Unraveling the Immediate Impacts of Olanzapine on Glucose Metabolism and Glucagon Signaling in Mice
Tushmitha Sundaralingam, Greg C. Smith, Margaret J. Morris, et al.
(2023)
Closed Access

Page 1

Scroll to top